IP Verse

Dihydrate Of Benzothiophene Compound Or Of A Salt Thereof, And Process For Producing The Same - EP2841431

The patent EP2841431 was granted to Otsuka Pharmaceutical on Jan 24, 2024. The application was originally filed on Apr 23, 2013 under application number EP13722129A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2841431

OTSUKA PHARMACEUTICAL
Application Number
EP13722129A
Filing Date
Apr 23, 2013
Status
Patent Maintained As Amended
Dec 22, 2023
Grant Date
Jan 24, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GEORG KALHAMMERSTEPHAN TEIPELSep 28, 2017-ADMISSIBLE

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONJP2006316052
EXAMINATIONEP2868318
INTERNATIONAL-SEARCH-REPORTUS2011152286
OPPOSITIONWO2005041937
OPPOSITIONWO2012026562

Non-Patent Literature (NPL) Citations (9) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- "Brexpiprazole", Wikipedia, (20120311), XP055426855-
OPPOSITION- "Chapter 9 - Solid-state properties", M. E. AULTON, Pharmaceutics. The Science of Dosage Form Design, (20020000), pages 141 - 145, ISBN 04443055173-
OPPOSITION- "Chapter 9 - Solid-state properties", M. E. AULTON, Pharmaceutics. The Science of Dosage Form Design, (20020000), pages 141 - 145, ISBN 04443055173, XP055426926-
OPPOSITION- D. F. WONG et al., "A Phase I, Open-Label PET Study of the Pharmacokinetics, Tolerability and D2/D3 Striatal Occupancy of Single-Dose Oral OPC-34712 in Healthy Subjects", Society of Biological Psychiatry 2011 Annual Meeting , Biol. Psychiatry, (20110000), vol. 69, pages 1S - 290S, XP009168836-
OPPOSITION- Li et al, 'Preparation and evaluation of progesterone nanocrystals to decrease muscle irritation and improve bioavailability', AAPS PharmSciTech vol 19, no 3, 2018, 1254-1263-
OPPOSITION- "Otsuka HD Places Top Priority on Development of OPC-34712", Pharma Japan, (20110103), vol. 2219, page 3, XP055426920-
OPPOSITION- T. KIKUCHI et al., "Preclinical Pharmacology of OPC-34712: A Novel Compound with Dopamine D2 Receptor Partial Agonist Activity", Society of Biological Psychiatry 2011 Annual Meeting , Biol. Psychiatry, (20110000), vol. 69, pages 1S - 290S, XP009168835-
OPPOSITION- D. E. BRAUN et al., "Stability of Solvates and Packing Systematics of Nine Crystal Forms of Antipsychotic Drug Aripiprazole", Crystal Growth & Design, (20090000), vol. 9, no. 2, pages 1054 - 1065, XP055026586
OPPOSITION- S. BYRN et al., "Pharmaceutical Solids: A strategic Approach to Regulatory Considerations", Pharmaceutical Research, (19950000), vol. 12, no. 7, pages 945 - 954, XP055399407

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents